Noile-Immune Biotech Inc. (4893.T)
JPY 137.0
(-0.72%)
JPY 137.0
(-0.72%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 314.56 Million JPY | -49.16% |
| 2022 | 618.7 Million JPY | 694.91% |
| 2021 | 77.83 Million JPY | -17.47% |
| 2020 | 94.3 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.39 Million JPY | -4.7% |
| 2024 Q2 | - JPY | -100.0% |
| 2023 Q4 | 2.51 Million JPY | -99.17% |
| 2023 Q3 | 302.54 Million JPY | 12218.49% |
| 2023 FY | 314.56 Million JPY | -49.16% |
| 2023 Q1 | 7.05 Million JPY | 135.1% |
| 2023 Q2 | 2.45 Million JPY | -65.18% |
| 2022 Q4 | 3 Million JPY | 0.0% |
| 2022 FY | 618.7 Million JPY | 694.91% |
| 2021 FY | 77.83 Million JPY | -17.47% |
| 2020 FY | 94.3 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 83.28% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -291.703% |
| GNI Group Ltd. | 22.43 Billion JPY | 98.598% |
| Linical Co., Ltd. | 3.77 Billion JPY | 91.675% |
| Trans Genic Inc. | 2.24 Billion JPY | 86.015% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -220.157% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 87.328% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | 75.665% |
| AnGes, Inc. | -3.06 Billion JPY | 110.262% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 277.0% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 96.745% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | 39.191% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | -183.501% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | 78.315% |
| CanBas Co., Ltd. | -984 Million JPY | 131.968% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | 19.693% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 81.006% |
| Chiome Bioscience Inc. | 398.59 Million JPY | 21.083% |
| Kidswell Bio Corporation | 1.03 Billion JPY | 69.736% |
| PeptiDream Inc. | 17.21 Billion JPY | 98.173% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -927.809% |
| Ribomic Inc. | -10.5 Million JPY | 3095.249% |
| SanBio Company Limited | -14.5 Million JPY | 2268.788% |
| Healios K.K. | 108 Million JPY | -191.26% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 92346.628% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 632.739% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 20904.299% |
| StemRIM | -44.34 Million JPY | 809.285% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 90.124% |
| FunPep Company Limited | -680.28 Million JPY | 146.239% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -354.24% |
| Stella Pharma Corporation | 217.29 Million JPY | -44.76% |
| TMS Co., Ltd. | -6.95 Million JPY | 4626.058% |
| Cuorips Inc. | 9.63 Million JPY | -3166.13% |
| K Pharma,Inc. | 910 Million JPY | 65.433% |
| Takara Bio Inc. | 25.45 Billion JPY | 98.764% |
| ReproCELL Incorporated | 1.1 Billion JPY | 71.526% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | 73.678% |
| StemCell Institute Inc. | 1.57 Billion JPY | 80.039% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 81.128% |
| CellSeed Inc. | 107.15 Million JPY | -193.557% |